With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Medtronic (NYSE:MDT) this week shared new clinical data supporting its Evolut Pro/Pro+ transcatheter aortic valve replacement ...

Medtronic has reported new clinical data from the study of ... It reported a low rate of new 30-day permanent pacemaker ...

"With the help of a device company [Medtronic], we were working on a new pacemaker planned for another patient, that didn't ...

Medtronic has reported revenue gains across several of its ... The company also reported “high-teens growth” of its Micra ...

Medtronic plc's Q2 earnings show moderate growth, highlighting potential for shareholder value through strategic initiatives.

Medtronic is raising its full-year guidance following second-quarter results that came in ahead of the consensus forecast.

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Medtronic (MDT – Research Report) yesterday and set a price target of ...

Heavenleigh desperately needed a fix for her heart, and a family who needed her just as much as she needed them.